| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.25 － 2 |
LBM415 (NVP-PDF-713, VIC-10495)  |
162 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Daptomycin (Cubicin) |
16 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
16 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.03 － 2 |
Daptomycin + 25 μg/ml Ca++ |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.125 － 4 |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
89 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
73 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
4 |
0.12 － 16 |
Teicoplanin (Targocid) |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
4 |
≤0.12 － 16 |
Teicoplanin (Targocid) |
162 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
8 |
0.125 － 16 |
Teicoplanin (Targocid) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
8 |
0.25 － 16 |
Teicoplanin (Targocid) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
16 |
0.03 － 64 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.25 － 4 |
Oritavancin (LY333328) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 － 2 |
Oritavancin (LY333328) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
4 |
0.5 － 4 |
Meticillin (Methicillin, Staphcillin) |
178 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
8 |
≤0.06 － 16 |
Ceftriaxone (Rocephin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
8 |
≤0.12 － 16 |
Teicoplanin (Targocid) |
73 |